| 1 | 20 mg sildenafil citrate by mouth (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2 | 5% sildenafil cream (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 50 50 💬
|
| 3 | Access program - sildenafil citrate, Viagra, Revatio (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 4 | Bosentan and Sildenafil (D08514) | 2件: Bosentan Bosentan, Sildenafil | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 5 | Duo-Therapy with Sildenafil + Bosentan (D08514) | 2件: Bosentan Bosentan, Sildenafil | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 6 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (D08514) | 4件: Bosentan Bosentan, Macitentan, Sildenafil, Tadalafil | 5件: Bosentan
Bosentan
,
Tadalafil
,
Bosentan
,
Sildenafil
(D08514),
Macitentan
💬
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 7 | G04BE03- Sildenafil - sildenafil (citrato) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 8 | Mono-Therapy with Sildenafil (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 9 | Oral sildenafil (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 10 | Sildenafil (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 11 | Sildenafil (50 mg) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 12 | Sildenafil (Acute-1 hour) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
| 13 | Sildenafil (as citrate) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 14 | Sildenafil (REVATIO) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 15 | Sildenafil (Revatio) 20 mg TID (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 16 | Sildenafil (Subchronic-4 weeks) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
| 17 | Sildenafil 20 mg tablets (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 278 278 💬
|
| 18 | Sildenafil 20mg (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬
|
| 19 | Sildenafil 20mg and Bosentan 62.5mg (D08514) | 2件: Bosentan Bosentan, Sildenafil | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬
|
| 20 | Sildenafil 40mg oral capsule (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
| 21 | Sildenafil and Losartan (D08514) | 2件: Losartan Losartan, Sildenafil | 2件: Losartan
Losartan
,
Sildenafil
(D08514) 💬
| 2件: AGTR1 AGTR1, PDE5A 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 22 | Sildenafil by injection (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 210 210 💬
|
| 23 | SILDENAFIL CITRATE (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 85, 86, 225 💬
|
| 24 | Sildenafil citrate (UK-92,480) (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 25 | Sildenafil Filmtabletten (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 26 | Sildenafil Oral Suspension (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 294 294 💬
|
| 27 | Sildenafil singly or in association with Bosentan (D08514) | 2件: Bosentan Bosentan, Sildenafil | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬
| 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 28 | Sildenafil therapy (D08514) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 29 | Sitaxsentan and Sildenafil (D08514) | 2件: Sildenafil Sildenafil, Sitaxentan | 2件: Sitaxentan
Sitaxentan
,
Sildenafil
(D08514) 💬
| 2件: EDNRA EDNRA, PDE5A 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 30 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth (D08514) | 2件: Dextrose, unspecified form Dextrose, unspecified form, Sildenafil | 1件: Sildenafil
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 31 | Tadalafil and Sildenafil (D08514) | 2件: Sildenafil Sildenafil, Tadalafil | 2件: Tadalafil
Tadalafil
,
Sildenafil
(D08514) 💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬
|